panitumumab,bevacizumab
amgen,takeda,roche
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'paradigm']
outstanding discussion by dr. cremolini of #mcrc paradigm trial. do you agree with her treatment algorithm of folfoxiri-bev for pts with kras-mt left-sided tumors? #asco2022 
Oncologist. SVP Medical Informatics @Change_HC. Adjunct Professor @DukeMedSchool. Photographer. Trying to survive w/o travel (and failing).